SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-295582
Filing Date
2019-11-19
Accepted
2019-11-19 16:30:57
Documents
3
Period of Report
2019-11-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d24594d8k.htm 8-K 21622
2 EX-10.1 d24594dex101.htm EX-10.1 216231
3 EX-99.1 d24594dex991.htm EX-99.1 23281
  Complete submission text file 0001193125-19-295582.txt   262350
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38959 | Film No.: 191231623
SIC: 2834 Pharmaceutical Preparations